文献速递心脏核医学

[99mTc]Tc-HMDP SPECT/CT心肌与血池比值检测ATTR心肌病的验证

Validation of [99mTc]Tc-HMDP SPECT/CT myocardium-to-blood ratio for the detection of ATTR cardiomyopathy.
PubMed 文献 · J Nucl Cardiol · 2025-03-28

本研究在芬兰两家医院80例疑似ATTR心肌病患者中验证[99mTc]Tc-HMDP SPECT/CT心肌与血池比值(MBR)的诊断准确性,按欧洲心脏病学会标准分为非ATTR组48例和ATTR心肌病组32例。左心室MBR在ATTR组高于非ATTR组(4.6±1.2 vs 0.9±0.2,P<.001),左心室MBR>1.5检测ATTR心肌病的准确性为100%。左心室MBR与超声心动图左心室壁厚度相关,但与左心室射血分数、E/e'及ATTR心肌病临床严重程度无关。

要点

  • 左心室MBR在ATTR组为4.6±1.2,非ATTR组为0.9±0.2(P<.001)。
  • 左心室MBR>1.5检测ATTR心肌病的准确性为100%。
  • 左心室MBR与超声心动图左心室壁厚度相关,但与临床严重程度无关。

核心结论

  • 左心室心肌与血池比值(MBR)>1.5使用[99mTc]Tc-HMDP SPECT/CT检测ATTR心肌病的准确性为100%。
  • 左心室MBR与超声心动图左心室壁厚度相关,但与ATTR心肌病临床严重程度无关。

研究设计与样本

  • 研究在芬兰赫尔辛基大学医院或约尔维中央医院纳入80例疑似ATTR心肌病并接受[99mTc]Tc-HMDP SPECT/CT检查的患者。
  • 按现行欧洲心脏病学会标准将患者诊断为非ATTR(n=48)或ATTR心肌病(n=32)。
  • 左心室MBR计算为左心室心肌最大摄取除以左心房最大摄取,右心室摄取计算为右心室游离壁与右心房最大摄取比值。
  • 数据以均值±标准差表示。

主要发现

  • 左心室MBR在ATTR组为4.6±1.2,高于非ATTR组的0.9±0.2(P<.001)。
  • 左心室MBR>1.5检测ATTR心肌病的准确性为100%。
  • 单变量分析中左心室MBR与超声心动图左心室壁厚度相关,但与左心室射血分数或E/e'无关。
  • 右心室MBR在ATTR组为2.9±1.0,高于非ATTR组的0.8±0.2(P<.001)。
  • 单变量分析中左心室MBR和右心室MBR均与ATTR心肌病临床严重程度无关。

关键数值与推荐

  • 左心室MBR>1.5使用[99mTc]Tc-HMDP SPECT/CT检测ATTR心肌病的准确性为100%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study validates the accuracy of 99mTc-hydroxymethylene diphosphonate ([99mTc]Tc-HMDP) single-photon emission tomography/computed tomography (SPECT/CT) in the diagnosis of transthyretin amyloidosis (ATTR) cardiomyopathy using myocardium-to-blood ratio (MBR). METHODS: The final study population was 80 patients who underwent [99mTc]Tc-HMDP SPECT/CT for suspected ATTR cardiomyopathy at Helsinki University Hospital or Jorvi Central Hospital in Finland. Patients were diagnosed according to the currently accepted European Society of Cardiology criteria as either non-ATTR (n = 48) or ATTR cardiomyopathy patients (n = 32). The left ventricular (LV) MBR was calculated by dividing LV maximal myocardial uptake with maximal left atrial uptake. Right ventricular (RV) uptake was calculated as the maximal uptake ratio on the RV-free wall and right atrium. Data are presented as mean ± standard deviation. RESULTS: The LV MBR was higher in ATTR patients than in non-ATTR patients (4.6 ± 1.2 vs .9 ± .2, P < .001). The LV MBR of 1.5 identified ATTR cardiomyopathy with 100% accuracy. LV MBR was associated with LV wall thickness on echocardiography in univariable analysis but not with LV ejection fraction or E/e'. The RV MBR was higher in ATTR patients (2.9 ± 1.0 vs .8 ± .2, P < .001). Neither LV nor RV MBR were associated with the clinical severity of ATTR cardiomyopathy in univariable analysis. CONCLUSIONS: LV myocardium-to-blood ratio (MBR) greater than 1.5 was 100% accurate for detecting ATTR cardiomyopathy using [99mTc]Tc-HMDP SPECT/CT. Left ventricular MBR was associated with wall thickness on echocardiography but not with the clinical severity of ATTR cardiomyopathy.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Suomalainen O, Ahokas T, Hippeläinen E, et al. Validation of [99mTc]Tc-HMDP SPECT/CT myocardium-to-blood ratio for the detection of ATTR cardiomyopathy. J Nucl Cardiol. 2025. PMID: 40158722. doi:10.1016/j.nuclcard.2025.102199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。